| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/08/2007 | WO2007014432A1 Peptide conjugate for oral delivery of hydrophilic peptide analgesics |
| 02/08/2007 | WO2003068934A3 Chimeric molecules for cleavage in a treated host |
| 02/08/2007 | US20070032638 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2617449A1 Peptide conjugate for oral delivery of hydrophilic peptide analgesics |
| 02/08/2007 | CA2616987A1 Mutated pseudomonas exotoxins with reduced antigenicity |
| 02/08/2007 | CA2616898A1 Cd33-specific single-chain immunotoxin and method of use |
| 02/07/2007 | EP1749889A1 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749833A1 Super-antigens derived from the SARS coronavirus E2 spike protein |
| 02/07/2007 | EP1497634A4 Protein knobs |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | CN1910276A Chimeric empty capsids of the infectious bursal disease virus (IBDV), obtainment process and applications |
| 02/07/2007 | CN1908157A Yeast stain for preparing Pres-E1-E2 vaccine of hepatitis B and hepatitis C virus and preparation method thereof |
| 02/07/2007 | CN1908016A Fusion protein with protein transduction structure field TAT-PTD and application thereof |
| 02/07/2007 | CN1908015A Stabilized small molecule polypeptide capable of inhibiting HER2 high expression tumour cell proliferation |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/07/2007 | CN1908004A Purification of nasopharyngeal carcinoma related gene UBAP1 coding protein and preparation of antibody thereof |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/07/2007 | CN1298743C Fusion protein, gene encoding same, and use thereof |
| 02/07/2007 | CN1298742C A fusion protein suitable to highly effective expression and production method thereof |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2171557C A secretion sequence for the production of a heterologous protein in yeast |
| 02/01/2007 | WO2007013391A1 Interferon-inducible molecule ips-1 |
| 02/01/2007 | WO2006082406A3 Human antibodies and proteins |
| 02/01/2007 | WO2006069262A3 Compositions of influenza viral proteins and methods of use thereof |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | CN1903881A Antitumour multitarget composite antigen, its coding gene and application |
| 01/31/2007 | CN1903880A Antitumour vascular endothelial growth factor VEGF-E antigen, its coding gene and application |
| 01/31/2007 | CN1903875A Antitumour integrator alpha V beta 3 antigen and its coding gene and application |
| 01/31/2007 | CN1297567C Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169581 IL-18 receptors |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/25/2007 | WO2007011670A2 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | WO2007010989A1 Neuronal differentiation-inducing peptide and use thereof |
| 01/25/2007 | WO2007010128A1 Target vector with activable imaging function |
| 01/25/2007 | WO2006097708A3 Affinity purification of protein |
| 01/25/2007 | WO2006039238A3 Irta2 antibodies and methods of use |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070020745 Method for crystallizing human GSK3 and novel crystal structure thereof |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | CA2614567A1 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1745078A1 Method for the purification of albumin conjugates |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1259627B1 Heterologous expression of neisserial proteins |
| 01/24/2007 | EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/24/2007 | EP1012312B1 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | CN1901932A Cytokine antagonist molecules |
| 01/24/2007 | CN1900120A Fusion protein containing haman parathyroxin 1-34 and its expression vector |
| 01/24/2007 | CN1900119A Staphylococcus aureus enterotoxin 1 and preparation and use |
| 01/24/2007 | CN1900118A No-adjuvant therapeutic protein vaccine containing heat shock protein and HPV 16Z protein antigen |
| 01/24/2007 | CN1900117A Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166703 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 01/23/2007 | US7166701 Human survivin interacting protein 1 (SIP-1) |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166446 Vector with nucleotide sequence that comprises a yeast-recognized transcription and translation initiation and termination region; coding amino acid sequence for hybrid precursor polypeptide linked to heterologous mammalian protein such as platelet derived growth factor; genetic engineering |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015229 Secretory or membrane-binding chimeric protein |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | CA2614444A1 Compositions and methods for increasing amplification efficiency |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1078072B1 New peptide fragments for protein purification |